Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer (Q77848976)
Jump to navigation
Jump to search
scientific article published on 01 January 1998
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer |
scientific article published on 01 January 1998 |
Statements
Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer (English)
K Rajagopalan
D Peereboom
G T Budd
T Olencki
S Murthy
P Elson
D McLain
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference